Robeco Institutional Asset Management
BIVV

Robeco Institutional Asset Management’s Bioverativ Inc. Common Stock BIVV Stock Holding History

Robeco Institutional Asset Management’s Portfolio BIVV Stock Details BIVV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2018
Q1 		– Sell
-1,946
Closed -$105K – 977
2017
Q4 		$105K Buy
+1,946
New +$106K ﹤0.01% 863
2017
Q2 		– Sell
-3,472
Closed -$189K – 905
2017
Q1 		$189K Buy
+3,472
New +$171K ﹤0.01% 796

Other funds holding BIVV

IA
IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return
ACS
Archford Capital Strategies Swansea, Illinois $987M AUM 29.31% 1-Year Est. Return

Robeco Institutional Asset Management's BIVV Position: Q1 2018 in Review

Robeco Institutional Asset Management sold out of Bioverativ Inc. Common Stock (BIVV) in Q1 2018, closing a stake of 1,946 shares — an estimated $105K sold.

Robeco Institutional Asset Management first reported a position in BIVV in Q1 2017 and held it in 2 quarters. The position peaked at $189K in Q1 2017. 2 funds tracked by Wall St. Rank hold BIVV as of Q1 2018.

  • Robeco Institutional Asset Management reported no remaining Bioverativ Inc. Common Stock position as of Q1 2018 after selling out during the quarter.
  • Robeco Institutional Asset Management sold 1,946 Bioverativ Inc. Common Stock shares in Q1 2018, an estimated $105K.
  • Robeco Institutional Asset Management first reported a position in Bioverativ Inc. Common Stock in Q1 2017 and held it in 2 quarters.
  • Robeco Institutional Asset Management's Bioverativ Inc. Common Stock position peaked at $189K in Q1 2017.
  • 2 funds tracked by Wall St. Rank held Bioverativ Inc. Common Stock as of Q1 2018.

Based on Robeco Institutional Asset Management's 13F filing for Q1 2018, filed 7 May 2018.